Yossi Maimon
2011 - Protalix BioTherapeutics
In 2011, Yossi Maimon earned a total compensation of $373.8K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Option Awards | $18,304 |
|---|---|
| Salary | $286,220 |
| Other | $69,290 |
| Total | $373,814 |
Maimon received $286.2K in salary, accounting for 77% of the total pay in 2011.
Maimon also received $18.3K in option awards and $69.3K in other compensation.
Rankings
In 2011, Yossi Maimon's compensation ranked 8,878th out of 10,747 executives tracked by ExecPay. In other words, Maimon earned more than 17.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,878 out of 10,747 | 17th |
Division Manufacturing | 3,310 out of 3,960 | 16th |
Major group Chemicals And Allied Products | 837 out of 1,033 | 19th |
Industry group Drugs | 617 out of 781 | 21st |
Industry Biological Products, Except Diagnostic Substances | 111 out of 157 | 29th |
Source: SEC filing on October 9, 2014.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2011.
2011
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2011
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
2011
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2011
Einat Almon
Protalix BioTherapeutics